tert-Butyl 3-(2-ethoxy-2-oxoethyl)-3-(oxiran-2-yl)azetidine-1-carboxylate

Catalog No.: 
ACKQJT257
CAS No.: 
2137772-68-8
Molecular Formula: 
C14H23NO5
Molecular Weight: 
285.34
tert-Butyl 3-(2-ethoxy-2-oxoethyl)-3-(oxiran-2-yl)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$304.00InquiryInquiry
100mg98%$445.00InquiryInquiry
250mg98%$626.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(2-ethoxy-2-oxoethyl)-3-(oxiran-2-yl)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(2-ethoxy-2-oxoethyl)-3-(oxiran-2-yl)azetidine-1-carboxylate
Molecular FormulaC14H23NO5
Molecular Weight285.34
SMILESO=C(N1CC(C2OC2)(CC(OCC)=O)C1)OC(C)(C)C
InChI KeyHVKCZPKQURXTSS-UHFFFAOYSA-N
Synonymtert-butyl 3-(2-ethoxy-2-oxoethyl)-3-(oxiran-2-yl)azetidine-1-carboxylate;3-Azetidineacetic acid, 1-[(1,1-dimethylethoxy)carbonyl]-3-(2-oxiranyl)-, ethyl ester
CAS No.2137772-68-8

Synthetic Route by SureRoute

1. ACKQJT257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNXUH296 route compound structure diagram
    ACNXUH2961774-47-6In Stock
  4. Then
  5. ACKQJT257 route product structure diagram
    ACKQJT2572137772-68-8
Inquiry

2. ACKQJT257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKQJT257 route product structure diagram
    ACKQJT2572137772-68-8
Inquiry

3. ACKQJT257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKQJT257 route product structure diagram
    ACKQJT2572137772-68-8
Inquiry

Comments (0)